BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 38251656)

  • 1. Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies.
    Zhang X; An M; Zhang J; Zhao Y; Liu Y
    J Drug Target; 2024 Dec; 32(3):241-257. PubMed ID: 38251656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in research on the role of amino acid metabolic reprogramming in tumour therapy: A review.
    Wang D; Wan X
    Biomed Pharmacother; 2022 Dec; 156():113923. PubMed ID: 36411616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate in the tumour microenvironment: From immune modulation to therapy.
    Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
    EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
    Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer metabolic reprogramming and immune response.
    Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
    Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
    Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer metabolism: looking forward.
    Martínez-Reyes I; Chandel NS
    Nat Rev Cancer; 2021 Oct; 21(10):669-680. PubMed ID: 34272515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming of the tumour microenvironment.
    Xing Y; Zhao S; Zhou BP; Mi J
    FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
    Hao X; Ren Y; Feng M; Wang Q; Wang Y
    Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, metabolites, and macrophages in cancer.
    Li M; Yang Y; Xiong L; Jiang P; Wang J; Li C
    J Hematol Oncol; 2023 Jul; 16(1):80. PubMed ID: 37491279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
    Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
    Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
    Seo J; Yun JE; Kim SJ; Chun YS
    Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of intrinsic and extrinsic metabolic pathways in tumour-associated macrophages.
    Davuluri GVN; Chan CH
    FEBS J; 2023 Jun; 290(12):3040-3058. PubMed ID: 35486022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Cao X; Geng Q; Fan D; Wang Q; Wang X; Zhang M; Zhao L; Jiao Y; Deng T; Liu H; Zhou J; Jia L; Xiao C
    Mol Cancer; 2023 Mar; 22(1):42. PubMed ID: 36859310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.
    Elia I; Haigis MC
    Nat Metab; 2021 Jan; 3(1):21-32. PubMed ID: 33398194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia Boosts Aerobic Glycolysis in Carcinoma: A Complex Process for Tumour Development.
    Zheng X; Fan H; Liu Y; Wei Z; Li X; Wang A; Chen W; Lu Y
    Curr Mol Pharmacol; 2022; 15(3):487-501. PubMed ID: 34382521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cellular energy metabolism- mediated ferroptosis by small molecule compounds for colorectal cancer therapy.
    Wang G; Wang JJ; Xu XN; Shi F; Fu XL
    J Drug Target; 2022 Sep; 30(8):819-832. PubMed ID: 35481396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.